TABLE 3.
Event | No. of occurrences in cohort |
|||
---|---|---|---|---|
Total placebo (n = 6) | 500 mg q8h (n = 6) | 1,000 mg q8h (n = 6) | 1,500 mg q12h (n = 6) | |
Diarrhea | 2 | |||
Hypoaesthesia | 1 | |||
Paraesthesia | 1 | |||
Flushing | 1 |
Multiple doses of CXA-101 or placebo (6 CXA-101, 2 placebo per cohort).